Growth Metrics

Zoetis (ZTS) Cash & Equivalents (2016 - 2025)

Zoetis (ZTS) has disclosed Cash & Equivalents for 14 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 16.36% to $2.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Dec 2025, up 16.36% year-over-year, with the annual reading at $2.3 billion for FY2025, 16.36% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $2.3 billion at Zoetis, up from $2.1 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $3.7 billion in Q2 2021, with the low at $1.4 billion in Q2 2025.
  • Average Cash & Equivalents over 5 years is $2.4 billion, with a median of $2.1 billion recorded in 2023.
  • The sharpest move saw Cash & Equivalents skyrocketed 84.62% in 2021, then tumbled 43.0% in 2023.
  • Over 5 years, Cash & Equivalents stood at $3.5 billion in 2021, then increased by 2.75% to $3.6 billion in 2022, then crashed by 43.0% to $2.0 billion in 2023, then decreased by 2.65% to $2.0 billion in 2024, then increased by 16.36% to $2.3 billion in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $2.3 billion, $2.1 billion, and $1.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.